Stock Taper
CNTN
CANTON STRATEGIC HOLDINGS INC
NASDAQ
$2.30
▲ UP 9.52% (0.20)

KEY STATISTICS

Market Cap$177.38 M
52w High$6.89
52w Low$1.75
Dividend Yield
Frequency
P/E-0.73
Volume3.88M
Shares Out.77.12M

COMPANY

LEADERSHIP

Mark Wendland
CHIEF EXECUTIVE
Mark Wendland

COMPENSATION 2026

Salary$0
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$0
Total$0

ABOUT

SECTOR
Healthcare
WENT PUBLIC
January 12, 2022
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
12

UPCOMING EARNINGS

DateDec 2, 2026
DayWednesday
Rev. Est.$1.50M
DEC
2
WED

SPLIT RECORD

DATETYPERATIO
2024-05-28Reverse1:15
2023-11-21Reverse1:25

PRICE

$2.30 ▲ UP 9.52% (+$0.20)
OVERLAYS
$2.17$2.25$2.339:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM2.30

About Canton Strategic Holdings Inc

https://www.cantonstrategic.com ↗

Tharimmune, Inc., founded in 2017 in Bridgewater, NJ, is a clinical-stage biotech developing therapies for inflammation, immunology, and pruritus, including TH104 for treating the rare liver disease PBC.

INDUSTRY

Biotechnology

A SERVICE CANTON STRATEGIC HOLDINGS INC IS KNOWN FOR

Digital Asset Treasury Strategy

Canton Strategic Holdings focuses on its digital asset treasury, leveraging Canton Coin and the Canton Network to promote institutional blockchain adoption, network security, and financial market digitization.

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book4
Overall Score2

INSIDER TRADES

DIRECTOR:
Nangalia Rishi
· —
2026-07-13
DIRECTOR:
Carter Pamela L
· —
2026-07-13
DIRECTOR:
Galvin Sean
· —
2026-07-13
DIRECTOR
Stetz Gary S.
Sale · 10.0K shares
2026-05-22

SECTORS PEERS

PEERPRICE
ANL$15.74COMPARE
APLM$23.42COMPARE
AIMD$1.48COMPARE
BLRX$2.49COMPARE
LNAI$2.33COMPARE
ICU$3.54COMPARE
ADTX$0.00COMPARE
MBRX$0.77COMPARE